Fracture Risk Assessment in Patients with Monoclonal Gammopathy of Undetermined Significance: Value of Bone...
Patients with gammopathy of undetermined significance (MGUS) were unable to be classified by bone mineral density (BMD) and trabecular bone score (TBS).
Researchers of a study presented at the 17th International Myeloma Workshop are aiming to characterize the longitudinal treatment pathway for patients with multiple myeloma
Independent predictors of early relapse multiple myeloma (MM) include TP53 mutation, high LDH levels, amp1q and IGLL5 mutation
Efficacy and Safety of Carfilzomib Pomalidomide-Dexamethasone in Relapsed and/or Refractory Multiple Myeloma: Pooled Analysis...
The triple combination of carflizomib, pomalidomide, and dexamethasone (KPd) is an effective, and well-tolerated option for patients with relapsed and/or refractory multiple myeloma
The results of a study presented at the 17th International Myeloma Workshop might provide the rational for predicting multiple myeloma (MM) patient status for targeted and immune therapy.